Rockefeller Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Rockefeller Capital Management's KNSA Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Kiniksa Pharmaceuticals (KNSA) stake by 35% in Q3 2026, selling an estimated $4.44M and leaving 113,057 shares worth $8.44M. The position accounts for 0.01% of the portfolio, ranked #804.
Rockefeller Capital Management first reported a position in KNSA in Q2 2020 and has held it in 16 quarters since. The position peaked at $11.1M in Q2 2026. 305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Rockefeller Capital Management held 113,057 shares of Kiniksa Pharmaceuticals worth $8.44M as of Q3 2026.
- Rockefeller Capital Management sold 60,381 Kiniksa Pharmaceuticals shares in Q3 2026, an estimated $4.44M.
- Kiniksa Pharmaceuticals made up 0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #804 holding.
- Rockefeller Capital Management first reported a position in Kiniksa Pharmaceuticals in Q2 2020 and has held it in 16 quarters since.
- Rockefeller Capital Management's Kiniksa Pharmaceuticals position peaked at $11.1M in Q2 2026.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.